Diversified Trust Co lifted its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 20.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,906 shares of the biotechnology company’s stock after buying an additional 2,054 shares during the quarter. Diversified Trust Co’s holdings in Axon Enterprise were worth $5,056,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in AXON. Legal & General Group Plc increased its position in Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after buying an additional 5,419 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $13,116,000. Wealth Enhancement Advisory Services LLC lifted its position in shares of Axon Enterprise by 93.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after buying an additional 11,262 shares during the last quarter. Teamwork Financial Advisors LLC lifted its position in shares of Axon Enterprise by 40.5% in the fourth quarter. Teamwork Financial Advisors LLC now owns 25,352 shares of the biotechnology company’s stock valued at $14,398,000 after buying an additional 7,307 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its stake in shares of Axon Enterprise by 21.1% during the 4th quarter. Clearbridge Investments LLC now owns 343,910 shares of the biotechnology company’s stock worth $195,317,000 after acquiring an additional 59,821 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Stock Performance
Shares of AXON stock opened at $423.40 on Friday. The firm has a 50 day moving average price of $413.25 and a two-hundred day moving average price of $485.61. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $34.13 billion, a PE ratio of 170.04, a price-to-earnings-growth ratio of 7.70 and a beta of 1.45. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91.
Insider Buying and Selling at Axon Enterprise
In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider directly owned 34,024 shares in the company, valued at $16,501,640. The trade was a 4.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares in the company, valued at approximately $1,739,619.04. This represents a 13.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 38,989 shares of company stock worth $19,090,083 in the last 90 days. Company insiders own 4.20% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently weighed in on AXON. UBS Group decreased their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Piper Sandler reaffirmed an “overweight” rating and set a $674.00 price target on shares of Axon Enterprise in a report on Monday, June 15th. Robert W. Baird set a $800.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 25th. Citigroup reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, TD Cowen decreased their price objective on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $712.75.
View Our Latest Stock Analysis on Axon Enterprise
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
- Five stocks we like better than Axon Enterprise
- SpaceX Was Just the Beginning—2 More Massive IPOs Are on Deck
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
